Cardiac MRI for Optimal Heart Failure Outcomes With CRT Upgrades
Status: | Recruiting |
---|---|
Conditions: | Cardiology |
Therapuetic Areas: | Cardiology / Vascular Diseases |
Healthy: | No |
Age Range: | 25 - 89 |
Updated: | 5/5/2018 |
Start Date: | January 1, 2018 |
End Date: | January 1, 2020 |
Contact: | Kenneth C Bilchick, MD |
Email: | bilchick@virginia.edu |
Phone: | 434-924-2465 |
This study will investigate the use of cardiac MRI in patients with standard ICDs and
pacemakers to inform how cardiac resynchronization therapy (CRT) can best be implemented in
these patient and which patients are the best candidates for CRT.
pacemakers to inform how cardiac resynchronization therapy (CRT) can best be implemented in
these patient and which patients are the best candidates for CRT.
The scientific premise of this proposal is that left and right ventricular (LV and RV)
structural characteristics in patients with existing cardiac implantable electronic devices
and heart failure who may benefit from an upgrade to a cardiac resynchronization therapy
(CRT) device can be assessed very effectively using cardiac MRI using sequences designed for
post-device imaging. Furthermore, a comparative analysis of the differences in LV/RV
structural characteristics in patients with existing devices referred for CRT upgrades versus
those with de novo CRT implants is expected to be very useful for developing effective
strategies for optimal patient selection for CRT upgrades and implementation of CRT upgrades
in appropriate patients. Patient selection for CRT upgrades is very important considering
that complication rates are higher than in de novo CRT procedures and nonresponse rates are
still high. With this in mind, we are performing a study of 100 patients, including 50
prospectively enrolled patients with LVEF less than or equal to 0.35 and New York Heart
Association class II-III heart failure, who will be compared with an existing cohort of 50
patients with recent de novo CRT implants, pre-CRT MRIs, and response data. The 50
prospectively enrolled patients having CRT upgrades will undergo a pre-CRT cardiac MRI,
pre-CRT/post-CRT echocardiography, and pre-CRT/post-CRT cardiopulmonary exercise testing. In
the first aim, we will assess differences in cardiac MRI findings between CRT upgrade
patients and de novo CRT patients. In the second aim, we will assess the impact of cardiac
MRI findings on LV reverse remodeling and cardiopulmonary capacity in the two groups. In
summary, we propose a comprehensive prospective CRT/MRI study in CRT upgrade patients with
comparison to a complete MRI dataset of patients with de novo CRT implants in order to
identify key differences in MRI findings in these cohorts and the impact of these MRI-based
scar and activation findings on clinical outcomes. We expect that our results will have a
significant public health impact for patients with heart failure referred for CRT upgrades.
structural characteristics in patients with existing cardiac implantable electronic devices
and heart failure who may benefit from an upgrade to a cardiac resynchronization therapy
(CRT) device can be assessed very effectively using cardiac MRI using sequences designed for
post-device imaging. Furthermore, a comparative analysis of the differences in LV/RV
structural characteristics in patients with existing devices referred for CRT upgrades versus
those with de novo CRT implants is expected to be very useful for developing effective
strategies for optimal patient selection for CRT upgrades and implementation of CRT upgrades
in appropriate patients. Patient selection for CRT upgrades is very important considering
that complication rates are higher than in de novo CRT procedures and nonresponse rates are
still high. With this in mind, we are performing a study of 100 patients, including 50
prospectively enrolled patients with LVEF less than or equal to 0.35 and New York Heart
Association class II-III heart failure, who will be compared with an existing cohort of 50
patients with recent de novo CRT implants, pre-CRT MRIs, and response data. The 50
prospectively enrolled patients having CRT upgrades will undergo a pre-CRT cardiac MRI,
pre-CRT/post-CRT echocardiography, and pre-CRT/post-CRT cardiopulmonary exercise testing. In
the first aim, we will assess differences in cardiac MRI findings between CRT upgrade
patients and de novo CRT patients. In the second aim, we will assess the impact of cardiac
MRI findings on LV reverse remodeling and cardiopulmonary capacity in the two groups. In
summary, we propose a comprehensive prospective CRT/MRI study in CRT upgrade patients with
comparison to a complete MRI dataset of patients with de novo CRT implants in order to
identify key differences in MRI findings in these cohorts and the impact of these MRI-based
scar and activation findings on clinical outcomes. We expect that our results will have a
significant public health impact for patients with heart failure referred for CRT upgrades.
Inclusion Criteria:
- Undergoing upgrade from an existing pacemaker or ICD to a CRT device.
Exclusion Criteria:
- inability to provide informed consent
- pregnancy
- presence of metal embedded in the body due to prior accident or injury, as documented
by skull films or other imaging
- cerebral aneurysm clips
- cochlear implants
- other metallic implants known to be contraindications to MRI (pacemakers and ICDs are
allowed)
- severe claustrophobia
- acute kidney injury
- acute renal failure
- gadolinium allergy
- abandoned leads
We found this trial at
1
site
1215 Lee St
Charlottesville, Virginia 22903
Charlottesville, Virginia 22903
(434) 924-0211
Phone: 434-924-2465
University of Virginia Health System UVA Health System includes a 604-bed hospital, level I trauma...
Click here to add this to my saved trials